CAS RN 1335210-23-5
Dolutegravir intermediate-1, TRC
High-purity organic molecules and analytical standards, strategically delivered worldwide to empower innovation and commercial success.
Dolutegravir intermediate-1, TRC
High-purity organic molecules and analytical standards, strategically delivered worldwide to empower innovation and commercial success.
Dolutegravir intermediate-1, TRC
High-purity organic molecules and analytical standards, strategically delivered worldwide to empower innovation and commercial success.
1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic Acid 2-Methyl Ester, Mikromol
Discover Mikromol- your trusted source for high-quality pharmaceutical reference standards. Supporting accurate, compliant analysis with ISO 17034-accredited materials designed for confidence in every result.
Dolutegravir intermediate-1, MedChemExpress
MedChemExpress Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.